Eric H. Bjerkholt
2012 - Sunesis Pharmaceuticals
In 2012, Eric H. Bjerkholt earned a total compensation of $672.6K as Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,000 |
|---|---|
| Option Awards | $153,588 |
| Salary | $367,500 |
| Other | $3,466 |
| Total | $672,554 |
Bjerkholt received $367.5K in salary, accounting for 55% of the total pay in 2012.
Bjerkholt also received $148K in non-equity incentive plan, $153.6K in option awards and $3.5K in other compensation.
Rankings
In 2012, Eric H. Bjerkholt's compensation ranked 7,714th out of 11,487 executives tracked by ExecPay. In other words, Bjerkholt earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,714 out of 11,487 | 33rd |
Division Manufacturing | 2,772 out of 4,253 | 35th |
Major group Chemicals And Allied Products | 721 out of 1,198 | 40th |
Industry group Drugs | 509 out of 920 | 45th |
Industry Pharmaceutical Preparations | 401 out of 700 | 43rd |
Source: SEC filing on April 25, 2013.
Bjerkholt's colleagues
We found three more compensation records of executives who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2012.